Inhibikase Therapeutics (IKT)
NASDAQ:IKT
Holding IKT?
Track your performance easily

Inhibikase Therapeutics (IKT) Technical Analysis

127 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Inhibikase Therapeutics’s (IKT) Moving Averages Convergence Divergence (MACD) indicator is 0.33, suggesting Inhibikase Therapeutics is a Sell.
Inhibikase Therapeutics’s (IKT) 20-Day exponential moving average is 2.40, while Inhibikase Therapeutics’s (IKT) share price is $2.88, making it a Buy.
Inhibikase Therapeutics’s (IKT) 50-Day exponential moving average is 1.95, while Inhibikase Therapeutics’s (IKT) share price is $2.88, making it a Buy.

Inhibikase Therapeutics (IKT) Pivot Points

Nov 10, 2024, 01:07 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.40
2.48
2.63
2.71
2.86
2.94
3.09
Fibonacci
2.48
2.57
2.62
2.71
2.80
2.85
2.94
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Inhibikase Therapeutics (IKT) Moving Averages

Nov 10, 2024, 01:07 AM
Period
Simple
Exponential
MA5
2.72Buy
2.75Buy
MA10
2.69Buy
2.64Buy
MA20
2.42Buy
2.40Buy
MA50
1.72Buy
1.95Buy
MA100
1.55Buy
1.74Buy
MA200
1.80Buy
1.73Buy
Inhibikase Therapeutics’s (IKT) 10-Day exponential moving average is 2.64, while Inhibikase Therapeutics’s (IKT) share price is $2.88, making it a Buy.
Inhibikase Therapeutics’s (IKT) 100-Day exponential moving average is 1.74, while Inhibikase Therapeutics’s (IKT) share price is $2.88, making it a Buy.
Inhibikase Therapeutics’s (IKT) stock price is $2.88 and Inhibikase Therapeutics’s (IKT) 50-day simple moving average is 1.72, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $2.88 and Inhibikase Therapeutics’s (IKT) 100-day simple moving average is 1.55, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $2.88 and Inhibikase Therapeutics’s (IKT) 200-day simple moving average is 1.80, creating a Buy signal.

Inhibikase Therapeutics (IKT) Technical Indicators

Nov 10, 2024, 01:07 AM
Name
Value
Implied Action
RSI (14)
71.55
Sell
STOCH (9,6)
69.47
Neutral
STOCHRSI (14)
80.10
Sell
MACD (12,26)
0.33
Sell
ADX (14)
47.12
Neutral
Williams %R
-45.25
Buy
CCI (14)
157.67
Sell
ATR (14)
0.29
-
Ultimate Oscillator
43.06
Neutral
ROC
29.73
Buy
Inhibikase Therapeutics’s (IKT) Relative Strength Index (RSI) is 71.55, creating a Sell signal.
Inhibikase Therapeutics’s (IKT) Trend Strength Indicator (ADX) is 47.12, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Commodity Channel Index (CCI) is 157.67, creating a Sell signal.
Inhibikase Therapeutics’s (IKT) Price Rate of Change (ROC) is 29.73, creating a Buy signal.

FAQ

Is IKT a Buy, Hold, or Sell?
Based on IKT’s technical indicators, IKT is a Buy.
    What is IKT’s RSI (14)?
    IKT’s RSI (14) is 71.55, which suggests IKT is a Sell.
      What is IKT’s MACD?
      IKT’s MACD is 0.33, which suggests IKT is a Sell.
        What is IKT’s 5-day moving average?
        IKT’s 5-day moving average is 2.72, which suggests IKT is a Buy.
          What is IKT’s 20-day moving average?
          IKT 20-day moving average is 2.42, which suggests IKT is a Buy.
            What is IKT’s 50-day moving average?
            IKT’s 50-day moving average is 1.72, which suggests IKT is a Buy.
              What is IKT’s 200-day moving average?
              IKT’s 200-day moving average is 1.80, which suggests IKT is a Buy.
                What is IKT’s Williams % R (14)?
                IKT’s Williams % R (14) is -45.25, which suggests IKT is a Buy.
                  What is IKT’s CCI (14)?
                  IKT’s CCI (14) is 157.67, which suggests IKT is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis